FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890592800> ?p ?o ?g. }

• W2890592800 endingPage "720" @default.
• W2890592800 startingPage "713" @default.
• W2890592800 abstract "The characteristics and management of invasive pulmonary aspergillosis (IPA) in patients with hematologic malignancies are well known, but IPA in patients with solid tumours is not well described.We retrospectively reviewed all Aspergillus-positive cultures at a tertiary cancer center during 2004-2017. We identified 101 patients with IPA and solid tumours. We analyzed the association between clinical features and treatment and 12-week mortality and response to antifungal therapy.Fifty-one patients had lung cancer, 77 had underlying lung disease, 47 received chest radiation and 33 had chronic obstructive pulmonary disease. Aspergillus fumigatus was the most common type isolated (71%); 68 patients (70%) were treated with voriconazole monotherapy. Independent risk factors for 12-week mortality included receiving steroids within 30 days of diagnosis (hazard ratio 2.2, 95% confidence interval [CI]: 1.1-4.6; p = .03) and chest radiotherapy (hazard ratio 2.6, 95% CI: 1.2-5.5; p = .01). In multivariate analysis, a positive fungal stain was associated with lower odds of a successful response (odds ratio 0.2; 95% CI: 0.05-0.75; p = .02), whereas voriconazole treatment was associated with higher odds (odds ratio 10.1; 95% CI: 2.1-48.5; p < .01).IPA should be considered in patients with solid tumours, particularly those with underlying lung disease. Key messages Invasive pulmonary aspergillosis should be considered in patients with solid tumours, particularly those with underlying lung disease, lung cancer and those who received chest radiotherapy. Most of the patients with invasive pulmonary aspergillosis and solid tumours presented with nonspecific symptoms and signs as well as nonspecific CT findings. Unlike patients with hematologic malignancies, fever and hemoptysis were not predominant symptoms and the classical halo sign and the air-crescent sign were not described. Independent risk factors for 12-week mortality included receiving steroids within 30 days of diagnosis and chest radiotherapy. In multivariate analysis, a positive fungal stain was associated with lower odds of a successful response to antifungal therapy, whereas voriconazole treatment was associated with higher odds." @default.
• W2890592800 created "2018-09-27" @default.
• W2890592800 creator A5000785564 @default.
• W2890592800 creator A5005773223 @default.
• W2890592800 creator A5007730121 @default.
• W2890592800 creator A5022649229 @default.
• W2890592800 creator A5033841614 @default.
• W2890592800 creator A5063320944 @default.
• W2890592800 creator A5083755423 @default.
• W2890592800 date "2018-09-29" @default.
• W2890592800 modified "2023-09-30" @default.
• W2890592800 title "Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes" @default.
• W2890592800 cites W1599702287 @default.
• W2890592800 cites W1974236199 @default.
• W2890592800 cites W1994377436 @default.
• W2890592800 cites W2009741328 @default.
• W2890592800 cites W2013887545 @default.
• W2890592800 cites W2019607817 @default.
• W2890592800 cites W2021785543 @default.
• W2890592800 cites W2026574962 @default.
• W2890592800 cites W2039458277 @default.
• W2890592800 cites W2076556610 @default.
• W2890592800 cites W2083551617 @default.
• W2890592800 cites W2098438303 @default.
• W2890592800 cites W2102731598 @default.
• W2890592800 cites W2106895832 @default.
• W2890592800 cites W2108396393 @default.
• W2890592800 cites W2142482664 @default.
• W2890592800 cites W2151939809 @default.
• W2890592800 cites W2158272308 @default.
• W2890592800 cites W2166734004 @default.
• W2890592800 cites W2167423543 @default.
• W2890592800 cites W2169522369 @default.
• W2890592800 cites W2170108937 @default.
• W2890592800 cites W2346946071 @default.
• W2890592800 cites W2470291098 @default.
• W2890592800 cites W2474061436 @default.
• W2890592800 cites W2514303199 @default.
• W2890592800 cites W2596189086 @default.
• W2890592800 cites W2741940869 @default.
• W2890592800 cites W2800916499 @default.
• W2890592800 cites W2801469916 @default.
• W2890592800 doi "https://doi.org/10.1080/07853890.2018.1518581" @default.
• W2890592800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30230385" @default.
• W2890592800 hasPublicationYear "2018" @default.
• W2890592800 type Work @default.
• W2890592800 sameAs 2890592800 @default.
• W2890592800 citedByCount "15" @default.
• W2890592800 countsByYear W28905928002020 @default.
• W2890592800 countsByYear W28905928002021 @default.
• W2890592800 countsByYear W28905928002022 @default.
• W2890592800 countsByYear W28905928002023 @default.
• W2890592800 crossrefType "journal-article" @default.
• W2890592800 hasAuthorship W2890592800A5000785564 @default.
• W2890592800 hasAuthorship W2890592800A5005773223 @default.
• W2890592800 hasAuthorship W2890592800A5007730121 @default.
• W2890592800 hasAuthorship W2890592800A5022649229 @default.
• W2890592800 hasAuthorship W2890592800A5033841614 @default.
• W2890592800 hasAuthorship W2890592800A5063320944 @default.
• W2890592800 hasAuthorship W2890592800A5083755423 @default.
• W2890592800 hasConcept C126322002 @default.
• W2890592800 hasConcept C141071460 @default.
• W2890592800 hasConcept C156957248 @default.
• W2890592800 hasConcept C16005928 @default.
• W2890592800 hasConcept C203014093 @default.
• W2890592800 hasConcept C207103383 @default.
• W2890592800 hasConcept C2776256026 @default.
• W2890592800 hasConcept C2776391196 @default.
• W2890592800 hasConcept C2779548794 @default.
• W2890592800 hasConcept C2780690907 @default.
• W2890592800 hasConcept C44249647 @default.
• W2890592800 hasConcept C71924100 @default.
• W2890592800 hasConcept C90924648 @default.
• W2890592800 hasConceptScore W2890592800C126322002 @default.
• W2890592800 hasConceptScore W2890592800C141071460 @default.
• W2890592800 hasConceptScore W2890592800C156957248 @default.
• W2890592800 hasConceptScore W2890592800C16005928 @default.
• W2890592800 hasConceptScore W2890592800C203014093 @default.
• W2890592800 hasConceptScore W2890592800C207103383 @default.
• W2890592800 hasConceptScore W2890592800C2776256026 @default.
• W2890592800 hasConceptScore W2890592800C2776391196 @default.
• W2890592800 hasConceptScore W2890592800C2779548794 @default.
• W2890592800 hasConceptScore W2890592800C2780690907 @default.
• W2890592800 hasConceptScore W2890592800C44249647 @default.
• W2890592800 hasConceptScore W2890592800C71924100 @default.
• W2890592800 hasConceptScore W2890592800C90924648 @default.
• W2890592800 hasIssue "8" @default.
• W2890592800 hasLocation W28905928001 @default.
• W2890592800 hasLocation W28905928002 @default.
• W2890592800 hasOpenAccess W2890592800 @default.
• W2890592800 hasPrimaryLocation W28905928001 @default.
• W2890592800 hasRelatedWork W1943617196 @default.
• W2890592800 hasRelatedWork W2063019936 @default.
• W2890592800 hasRelatedWork W2064447907 @default.
• W2890592800 hasRelatedWork W2135481547 @default.
• W2890592800 hasRelatedWork W2329364306 @default.
• W2890592800 hasRelatedWork W2793590385 @default.
• W2890592800 hasRelatedWork W2804529914 @default.

• next